Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND studyKristian Reich, Claire Clibborn, Jonathan I. Silverberg et al.|Journal of the European Academy of Dermatology and Venereology|2023Cited by 47
Measuring Atopic Eczema Control and Itch Intensity in Clinical PracticeYael A. Leshem, Norito Katoh, Louise A. A. Gerbens et al.|JAMA Dermatology|2022Cited by 36